<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fourteen patients with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and one with the <z:e sem="disease" ids="C0043194" disease_type="Disease or Syndrome" abbrv="">Wiskott-Aldrich syndrome</z:e> who were specifically sensitized against their donors were successfully engrafted with bone marrow from those donors </plain></SENT>
<SENT sid="1" pm="."><plain>Sensitivity was detected in antibody-independent and antibody-dependent cell-mediated lysis assays </plain></SENT>
<SENT sid="2" pm="."><plain>In order to erase this immunity to non-MHR familial transplantation antigens, multiagent immunosuppression with <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, procarbazine, and whole rabbit antithymocyte serum (ATS) was used </plain></SENT>
<SENT sid="3" pm="."><plain>The data suggest that ATS was largely responsible for abrogation of this sensitivity and indicate that immunity does not represent a barrier to successful transplantation </plain></SENT>
</text></document>